EU Commission President Ursula von der Leyen announced on Twitter that the European Union agreed on Saturday to a massive contract extension with pharmaceutical Pfizer-BioNTech. The new contract could garner a potential 1.8 billion COVID-19 doses through 2023 for the EU. Backed up by EU member states, the contract also ensures that all essential components should be sourced from the EU.
Happy to announce that @EU_Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with @BioNTech_Group @Pfizer for 2021-2023.
Other contracts and other vaccine technologies will follow.
— Ursula von der Leyen (@vonderleyen) May 8, 2021
With a portfolio of 2.3 billion doses from half a dozen companies, von der Leyen said that other contracts and vaccine technologies will follow for the EU. America’s Pfizer and Germany’s BioNTech had already stated that the EU would be provided with an extra 50 million doses in the 2nd quarter of 2021, to make up for Astra-Zeneca’s lack in deliveries.
#MaltaDaily
Photo Source: BioPharma Reporter, Ursula von der Leyen Twitter